Tags : Naciri & Associés

Deal & transactions Healthcare, Pharma & Life Sciences Other

Pharmaceutical Institute (PHI) completes acquisition by Kelix Bio 

KELIX bio, a pan-African biopharmaceutical platform, has entered into a binding agreement to acquire Moroccan Pharmaceutical Institute (“PHI”).  This investment marks KELIX bio’s first entry into Morocco – an important market in the company’s strategy – at a time when the Kingdom is accelerating the successful rollout of AMO (Assurance Maladie Obligatoire), a far-reaching plan […]